β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer

• Main Authors: Cong Xu (Author), Ze-Bo Jiang (Author), Le Shao (Author), Zi-Ming Zhao (Author), Xing-Xing Fan (Author), Xinbing Sui (Author), Li-Li Yu (Author), Xuan-Run Wang (Author), Ruo-Nan Zhang (Author), Wen-Jun Wang (Author), Ya-Jia Xie (Author), Yi-Zhong Zhang (Author), Xiao-Wen Nie (Author), Chun Xie (Author), Ju-Min Huang (Author), Jing Wang (Author), Jue Wang (Author), Elaine Lai-Han Leung (Author), Qi-Biao Wu (Author)
• Format: Book
• Published: Elsevier, 2023-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nearly half of all Asian non-small cell lung cancer (NSCLC) patients harbour epidermal growth factor receptor (EGFR) mutations, and first-generation EGFR tyrosine kinase inhibitors (TKIs) are one of the first-line treatments that have improved the outcomes of these patients. Unfortunately, 20% of th...